May 7, 2018 / 2:03 PM / 19 days ago

BRIEF-Aclaris Therapeutics Announces Availability Of Eskata In The U.S.

May 7 (Reuters) - Aclaris Therapeutics Inc:

* ACLARIS THERAPEUTICS ANNOUNCES AVAILABILITY OF ESKATA™ (HYDROGEN PEROXIDE) TOPICAL SOLUTION, 40% (W/W)

* ACLARIS THERAPEUTICS INC - ESKATA IS NOW AVAILABLE FOR PURCHASE BY DERMATOLOGISTS IN THE UNITED STATES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below